These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36369044)

  • 1. A split influenza vaccine formulated with a combination adjuvant composed of alpha-D-glucan nanoparticles and a STING agonist elicits cross-protective immunity in pigs.
    Patil V; Hernandez-Franco JF; Yadagiri G; Bugybayeva D; Dolatyabi S; Feliciano-Ruiz N; Schrock J; Hanson J; Ngunjiri J; HogenEsch H; Renukaradhya GJ
    J Nanobiotechnology; 2022 Nov; 20(1):477. PubMed ID: 36369044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the Efficacy of a Split Swine Influenza A Virus Nasal Vaccine Formulated with a Nanoparticle/STING Agonist Combination Adjuvant in Conventional Pigs.
    Patil V; Hernandez-Franco JF; Yadagiri G; Bugybayeva D; Dolatyabi S; Feliciano-Ruiz N; Schrock J; Suresh R; Hanson J; Yassine H; HogenEsch H; Renukaradhya GJ
    Vaccines (Basel); 2023 Nov; 11(11):. PubMed ID: 38006039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal Delivery of Inactivated Influenza Virus and Poly(I:C) Adsorbed Corn-Based Nanoparticle Vaccine Elicited Robust Antigen-Specific Cell-Mediated Immune Responses in Maternal Antibody Positive Nursery Pigs.
    Patil V; Renu S; Feliciano-Ruiz N; Han Y; Ramesh A; Schrock J; Dhakal S; HogenEsch H; Renukaradhya GJ
    Front Immunol; 2020; 11():596964. PubMed ID: 33391267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
    Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
    Front Immunol; 2018; 9():934. PubMed ID: 29770135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a novel functional porcine CD3
    Patil V; Yadagiri G; Bugybayeva D; Schrock J; Suresh R; Hernandez-Franco JF; HogenEsch H; Renukaradhya GJ
    Vet Immunol Immunopathol; 2024 Aug; 274():110785. PubMed ID: 38861830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity and Protective Efficacy of Mannose Conjugated Chitosan-Based Influenza Nanovaccine in Maternal Antibody Positive Pigs.
    Renu S; Feliciano-Ruiz N; Patil V; Schrock J; Han Y; Ramesh A; Dhakal S; Hanson J; Krakowka S; Renukaradhya GJ
    Front Immunol; 2021; 12():584299. PubMed ID: 33746943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyanhydride nanovaccine against swine influenza virus in pigs.
    Dhakal S; Goodman J; Bondra K; Lakshmanappa YS; Hiremath J; Shyu DL; Ouyang K; Kang KI; Krakowka S; Wannemuehler MJ; Won Lee C; Narasimhan B; Renukaradhya GJ
    Vaccine; 2017 Feb; 35(8):1124-1131. PubMed ID: 28117173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(I:C) augments inactivated influenza virus-chitosan nanovaccine induced cell mediated immune response in pigs vaccinated intranasally.
    Renu S; Feliciano-Ruiz N; Ghimire S; Han Y; Schrock J; Dhakal S; Patil V; Krakowka S; Renukaradhya GJ
    Vet Microbiol; 2020 Mar; 242():108611. PubMed ID: 32122615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs.
    Dhakal S; Cheng X; Salcido J; Renu S; Bondra K; Lakshmanappa YS; Misch C; Ghimire S; Feliciano-Ruiz N; Hogshead B; Krakowka S; Carson K; McDonough J; Lee CW; Renukaradhya GJ
    Int J Nanomedicine; 2018; 13():6699-6715. PubMed ID: 30425484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
    Thomas M; Wang Z; Sreenivasan CC; Hause BM; Gourapura J Renukaradhya ; Li F; Francis DH; Kaushik RS; Khatri M
    Vaccine; 2015 Jan; 33(4):542-8. PubMed ID: 25437101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal Vaccination against Influenza with a STING-Targeted Nanoparticle Combination Adjuvant Induces Superior Cross-Protective Humoral Immunity in Swine Compared with Intranasal and Intramuscular Immunization.
    Hernandez-Franco JF; Yadagiri G; Patil V; Bugybayeva D; Dolatyabi S; Dumkliang E; Singh M; Suresh R; Akter F; Schrock J; Renukaradhya GJ; HogenEsch H
    Vaccines (Basel); 2023 Nov; 11(11):. PubMed ID: 38006031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs.
    Dhakal S; Hiremath J; Bondra K; Lakshmanappa YS; Shyu DL; Ouyang K; Kang KI; Binjawadagi B; Goodman J; Tabynov K; Krakowka S; Narasimhan B; Lee CW; Renukaradhya GJ
    J Control Release; 2017 Feb; 247():194-205. PubMed ID: 28057521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs.
    Hiremath J; Kang KI; Xia M; Elaish M; Binjawadagi B; Ouyang K; Dhakal S; Arcos J; Torrelles JB; Jiang X; Lee CW; Renukaradhya GJ
    PLoS One; 2016; 11(4):e0151922. PubMed ID: 27093541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the NS1-truncated live attenuated influenza virus vaccine for swine against infection with viruses of major North American and European H3N2 lineages.
    Vandoorn E; Parys A; Chepkwony S; Chiers K; Van Reeth K
    Vaccine; 2022 Apr; 40(19):2723-2732. PubMed ID: 35367071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine model.
    Pliasas VC; Neasham PJ; Naskou MC; Neto R; Strate PG; North JF; Pedroza S; Chastain SD; Padykula I; Tompkins SM; Kyriakis CS
    Front Immunol; 2023; 14():1253626. PubMed ID: 37928521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bivalent live attenuated influenza virus vaccine protects against H1N2 and H3N2 viral infection in swine.
    Landreth S; Detmer S; Gerdts V; Zhou Y
    Vet Microbiol; 2021 Feb; 253():108968. PubMed ID: 33418392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs.
    Loving CL; Vincent AL; Pena L; Perez DR
    Vaccine; 2012 Aug; 30(40):5830-8. PubMed ID: 22835742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cold-passaged isolates and bat-swine influenza a chimeric viruses as modified live-attenuated vaccines against influenza a viruses in pigs.
    Graaf A; Petric PP; Sehl-Ewert J; Henritzi D; Breithaupt A; King J; Pohlmann A; Deutskens F; Beer M; Schwemmle M; Harder T
    Vaccine; 2022 Oct; 40(43):6255-6270. PubMed ID: 36137904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broadly Protective CD8
    Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
    J Virol; 2021 May; 95(12):. PubMed ID: 33827939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.